Harrow and Cencora Collaborate to Enhance Patient Care Access

Harrow Launches Harrow Cares Program Through Collaboration

NASHVILLE, Tenn. – Harrow, a prominent North American eyecare pharmaceutical company, has unveiled its innovative 'Harrow Cares' program as a result of a strategic partnership with Cencora. This initiative aims to make IHEEZO® and TRIESENCE® more accessible and affordable to retina specialists and their patients.

Comprehensive Support for Retina Specialists

The 'Harrow Cares' program is designed to provide a robust set of services that enhance support for retina specialists. The comprehensive suite includes advanced patient support services, ensuring easy enrollment and rapid access to vital therapies. This initiative is crucial in helping retina providers confidently utilize IHEEZO and TRIESENCE in their clinical practices.

About Cencora's Role

Cencora, known for its leading position in pharmaceutical solutions, contributes its expertise in market access optimization. By offering services such as real-time benefit verifications and flexible affordability options, Cencora greatly supports the healthcare providers in delivering patient care effectively.

Harrow's Commitment to Affordable Care

Mark L. Baum, Chief Executive Officer of Harrow, expressed enthusiasm about the partnership with Cencora. He stated that this collaboration is vital in addressing healthcare challenges related to the accessibility and affordability of essential medications. The 'Harrow Cares' initiative exemplifies Harrow's dedication to creating effective solutions that empower patients and enhance health outcomes in the retina market.

Key Features of the Harrow Cares Program

The 'Harrow Cares' program boasts several hallmark features that streamline access to treatments:

• Streamlined Enrollment: Providers can enroll patients through various channels such as phone, a dedicated provider portal, and the PXConnect technology integration.
• Rapid Access to Therapy: The program facilitates immediate benefit verifications, enabling retina specialists to quickly access and secure treatments.
• Flexible Affordability: This aspect includes commercial copay assistance, in-house patient assistance options, and connections to third-party charitable foundations, allowing patients to minimize their out-of-pocket expenses.
• Ongoing Assurance and Support: Patients benefit from services such as welcome calls, annual re-verification support, and assurance through product replacement programs, ensuring continuous care.

About Harrow, Inc.

Harrow, Inc. (Nasdaq: HROW) specializes in the discovery and commercialization of innovative ophthalmic pharmaceutical products tailored for the North American market. Its mission revolves around preserving patients' sight by ensuring that its diverse portfolio of pharmaceutical products remains accessible and affordable for millions of individuals.

Frequently Asked Questions

What is the Harrow Cares program?

The Harrow Cares program is a new initiative launched by Harrow in partnership with Cencora, aimed at providing improved access and affordability for retina specialists and their patients regarding treatments like IHEEZO and TRIESENCE.

How does Cencora contribute to the program?

Cencora enhances the program by offering its expertise in market access optimization, providing services that include real-time benefit verifications and patient affordability options.

What are the main benefits for patients in the Harrow Cares program?

Patients can benefit from streamlined enrollment, rapid access to necessary therapies, and options for affordability including in-house assistance and links to charitable resources.

What is Harrow’s mission?

Harrow aims to preserve the gift of sight for patients by ensuring its ophthalmic products are accessible and affordable, thereby promoting better health outcomes in eyecare.

How can healthcare providers enroll through the Harrow Cares program?

Providers have multiple enrollment options available, including online portals, phone enrollment, and integration via PXConnect technology to facilitate the process.

About The Author

Hi there I'm 38-year-old author and financial consultant Owen Jenkins. Having worked in the financial sector for more than ten years, I am well-versed in the subtleties and complexity that mold our financial environment. Following a degree in finance, I worked in a number of financial institutions honing my abilities in market analysis, financial planning, and investment strategies.

My love is teaching others about investing and personal finance. My goal in writing many books and articles has been to demystify financial ideas and give readers the information they need to make wise financial decisions. I write with a direct, useful style that emphasizes doable suggestions for daily living.

Along with writing, I lead webinars and seminars where I impart knowledge on how to successfully negotiate the financial world. I also write for financial journals and show up as a guest expert on financial news programs a lot. Whether they are new to investing or want to improve their approach, my mission is to enable people to take charge of their financial futures.

Beyond work, I like to hike, play the guitar, and spend time with my family. I think that balance is crucial and want to encourage people to strike a balance between their financial aspirations and their hobbies. I want to help people succeed and achieve financial security through my work, so having a good influence.

Contact Owen Jenkins here.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.